Micropulse Trans-Scleral Cyclophotocoagulation: A new Innovative Technology in Glaucoma Management

Published

2020-04-02

Dimensions Badge

Authors

  • Tanuja Kate

Abstract

Glaucoma is a progressive optic neuropathy and is the leading cause of irreversible blindness worldwide. The treatment of glaucoma aims to lower the intraocular pressure (IOP) by using medications, lasers and incisional surgery. Laser treatment in Glaucoma till now was in the form of YAG laser peripheral iridotomy, Laser trabeculoplasty and highly destructive cyclo photo coagulation using G probe. Diode laser micro pulsing has been shown in previous clinical and experimental studies to be useful in achieving targeted tissue damage and minimizing collateral thermal injury to adjacent tissues. Micropulse diode trans scleral cyclo photocoagulation (MP-TSCPC) has emerged as a new treatment option for glaucoma. The new Cyclo G6, Glaucoma laser system (Diode laser 810nm) is an innovative cyclo photocoagulation system with unique patented Micro Pulse technology. The Micro Pulse technology makes this laser safe and efficacious.

How to Cite

1.
Tanuja Kate. Micropulse Trans-Scleral Cyclophotocoagulation: A new Innovative Technology in Glaucoma Management. UPJO [Internet]. 2020 Apr. 2 [cited 2024 Oct. 16];8(02):59-61. Available from: https://upjo.org/index.php/upjo/article/view/441

Downloads

Download data is not yet available.